DE69522176D1 - Verfahren zur Dämpfung der Fluoreszenz von Fluoreszenzmarkierten Oligonukleotiden in Lösung - Google Patents
Verfahren zur Dämpfung der Fluoreszenz von Fluoreszenzmarkierten Oligonukleotiden in LösungInfo
- Publication number
- DE69522176D1 DE69522176D1 DE69522176T DE69522176T DE69522176D1 DE 69522176 D1 DE69522176 D1 DE 69522176D1 DE 69522176 T DE69522176 T DE 69522176T DE 69522176 T DE69522176 T DE 69522176T DE 69522176 D1 DE69522176 D1 DE 69522176D1
- Authority
- DE
- Germany
- Prior art keywords
- fluorescence
- label
- oligonucleotide
- damping
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6823—Release of bound markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/347,657 US5571673A (en) | 1994-11-23 | 1994-11-23 | Methods for in-solution quenching of fluorescently labeled oligonucleotide probes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69522176D1 true DE69522176D1 (de) | 2001-09-20 |
| DE69522176T2 DE69522176T2 (de) | 2002-05-29 |
Family
ID=23364666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69522176T Expired - Lifetime DE69522176T2 (de) | 1994-11-23 | 1995-11-15 | Verfahren zur Dämpfung der Fluoreszenz von Fluoreszenzmarkierten Oligonukleotiden in Lösung |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5571673A (de) |
| EP (1) | EP0713921B1 (de) |
| JP (1) | JP3600333B2 (de) |
| KR (1) | KR100431421B1 (de) |
| CN (1) | CN1131320C (de) |
| AT (1) | ATE204333T1 (de) |
| AU (1) | AU700885B2 (de) |
| CA (1) | CA2163388C (de) |
| DE (1) | DE69522176T2 (de) |
| DK (1) | DK0713921T3 (de) |
| ES (1) | ES2162630T3 (de) |
| NZ (1) | NZ280506A (de) |
| PT (1) | PT713921E (de) |
| RU (1) | RU2149186C1 (de) |
Families Citing this family (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5925517A (en) * | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
| US5837442A (en) | 1995-11-29 | 1998-11-17 | Roche Molecular Systems, Inc. | Oligonucleotide primers for amplifying HCV nucleic acid |
| US5763184A (en) | 1996-01-30 | 1998-06-09 | Roche Molecular Systems, Inc. | Nucleotide sequence variation in the ABO glycosyltransferase gene |
| DE69738687D1 (de) * | 1996-04-12 | 2008-06-26 | Phri Properties Inc | Sonden, kits und assays |
| US5691145A (en) * | 1996-08-27 | 1997-11-25 | Becton, Dickinson And Company | Detection of nucleic acids using G-quartets |
| US7803528B1 (en) | 1997-02-28 | 2010-09-28 | Quest Diagnostics Incorporated | Fluorescence energy transfer by competitive hybridization |
| US6503709B1 (en) | 1997-07-03 | 2003-01-07 | Id Biomedical Corporation | Methods for rapidly detecting methicillin resistant staphylococci |
| US6465175B2 (en) | 1997-09-04 | 2002-10-15 | Bayer Corporation | Oligonucleotide probes bearing quenchable fluorescent labels, and methods of use thereof |
| US6289229B1 (en) | 1998-01-20 | 2001-09-11 | Scimed Life Systems, Inc. | Readable probe array for in vivo use |
| US5952202A (en) * | 1998-03-26 | 1999-09-14 | The Perkin Elmer Corporation | Methods using exogenous, internal controls and analogue blocks during nucleic acid amplification |
| GB9815799D0 (en) * | 1998-07-21 | 1998-09-16 | Pharmagene Lab Limited | Quantitative analysis of gene expression |
| US6037130A (en) * | 1998-07-28 | 2000-03-14 | The Public Health Institute Of The City Of New York, Inc. | Wavelength-shifting probes and primers and their use in assays and kits |
| US7235358B2 (en) | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US6905827B2 (en) | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
| US7026121B1 (en) | 2001-06-08 | 2006-04-11 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| CA2457888A1 (en) * | 2001-08-23 | 2003-03-06 | Merck & Co., Inc. | Fluorescent multiplex hpv pcr assays using multiple fluorophores |
| DK1947104T3 (da) * | 2002-03-11 | 2012-08-06 | Lab 21 Ltd | Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C |
| DE60317420T2 (de) * | 2002-09-02 | 2008-09-18 | Toyo Boseki K.K. | Verfahren zu Identifizierung von Nukleotid-Polymorphismen unter Verwendung von Resonanzenergietransfer |
| ES2524048T3 (es) | 2003-03-31 | 2014-12-03 | F. Hoffmann-La Roche Ag | Composiciones y métodos para la detección de ciertos flavivirus, incluidos los miembros del serogrupo del virus de la encefalitis japonesa |
| WO2004094986A2 (en) | 2003-04-16 | 2004-11-04 | Handylab, Inc. | System and method for electrochemical detection of biological compounds |
| US7892745B2 (en) | 2003-04-24 | 2011-02-22 | Xdx, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US7939251B2 (en) | 2004-05-06 | 2011-05-10 | Roche Molecular Systems, Inc. | SENP1 as a marker for cancer |
| WO2006029184A2 (en) | 2004-09-08 | 2006-03-16 | Expression Diagnostics, Inc. | Genes useful for diagnosing and monitoring inflammation related disorders |
| US20100003665A1 (en) * | 2005-04-28 | 2010-01-07 | Taddeo Frank J | Real-time HPV PCR Assays |
| US11001881B2 (en) | 2006-08-24 | 2021-05-11 | California Institute Of Technology | Methods for detecting analytes |
| EP2029775B1 (de) * | 2006-06-05 | 2014-10-15 | California Institute Of Technology | Echtzeit-mikroarrays |
| WO2008014485A2 (en) | 2006-07-28 | 2008-01-31 | California Institute Of Technology | Multiplex q-pcr arrays |
| US11525156B2 (en) | 2006-07-28 | 2022-12-13 | California Institute Of Technology | Multiplex Q-PCR arrays |
| US7993832B2 (en) | 2006-08-14 | 2011-08-09 | Xdx, Inc. | Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders |
| US11560588B2 (en) | 2006-08-24 | 2023-01-24 | California Institute Of Technology | Multiplex Q-PCR arrays |
| WO2008140484A2 (en) | 2006-11-09 | 2008-11-20 | Xdx, Inc. | Methods for diagnosing and monitoring the status of systemic lupus erythematosus |
| WO2008119081A1 (en) | 2007-03-28 | 2008-10-02 | Signal Diagnostics | System and method for high resolution analysis of nucleic acids to detect sequence variations |
| FR2915208A1 (fr) * | 2007-04-20 | 2008-10-24 | Millipore Corp | Composition comprenant l'association d'edta et de pei pour augmenter la permeabilite des parois des microorganismes et utilisations de ladite composition |
| EP2185726B1 (de) | 2007-08-06 | 2014-01-08 | Orion Genomics, LLC | Neue einzelnukleotid-polymorphismen und kombinationen neuer und bekannter polymorphismen zur bestimmung der allelspezifischen expression des igf2-gens |
| JP2009077712A (ja) | 2007-09-11 | 2009-04-16 | F Hoffmann La Roche Ag | Ｂ−Ｒａｆキナーゼ阻害剤に対する感受性についての診断試験 |
| AU2009225835B2 (en) * | 2008-03-15 | 2013-02-14 | Hologic, Inc. | Compositions and methods for analysis of nucleic acid molecules during amplification reactions |
| US10669574B2 (en) | 2008-11-18 | 2020-06-02 | XCR Diagnostics, Inc. | DNA amplification technology |
| JP5748672B2 (ja) | 2009-02-11 | 2015-07-15 | オリオン ゲノミクス エルエルシー | Ｉｇｆ２の対立遺伝子特異的な発現を判定するための多型の組み合わせ |
| WO2011128096A1 (en) | 2010-04-16 | 2011-10-20 | Roche Diagnostics Gmbh | Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment |
| JP2014526900A (ja) | 2011-08-31 | 2014-10-09 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 血管新生阻害剤に対する応答性 |
| BR112014004763A2 (pt) | 2011-08-31 | 2017-03-21 | Hoffmann La Roche | método de determinação da susceptibilidade de pacientes ao desenvolvimento da hipertensão, composição farmacêutica, kit de condução, método de redução e método de tratamento de pacientes |
| EP2758055A1 (de) | 2011-09-19 | 2014-07-30 | F.Hoffmann-La Roche Ag | Kombinationsbehandlungen mit c-met antagonisten und b-raf antagonisten |
| MX2014006186A (es) | 2011-11-23 | 2014-07-14 | Hoffmann La Roche | Capacidad de respuesta a los inhibidores de la angiogenesis. |
| US10633707B2 (en) | 2012-04-10 | 2020-04-28 | Vib Vzw | Markers for detecting microsatellite instability in cancer and determining synthetic lethality with inhibition of the DNA base excision repair pathway |
| US10294529B2 (en) | 2012-04-10 | 2019-05-21 | Life Sciences Research Partners Vzw | Microsatellite instability markers in detection of cancer |
| US9828629B2 (en) | 2013-03-15 | 2017-11-28 | Roche Molecular Systems, Inc. | Nucleic acid target identification by structure based probe cleavage |
| WO2015054516A2 (en) | 2013-10-09 | 2015-04-16 | Fluoresentric, Inc. | Multiplex probes |
| US9637791B2 (en) | 2013-12-20 | 2017-05-02 | Roche Molecular Systems, Inc. | Multiplexed nucleic acid target identification by strucutre based probe cleavage |
| US20150176060A1 (en) | 2013-12-20 | 2015-06-25 | Roche Molecular Systems, Inc. | Method For Coding Of Multiple PCR Reactions For Assay Recognition |
| US9243289B2 (en) | 2013-12-23 | 2016-01-26 | Roche Molecular Systems, Inc. | Method for screening reagents used in PCR assays |
| US20160053302A1 (en) | 2014-04-22 | 2016-02-25 | Roche Molecular Systems, Inc. | Method for visual identification of pcr solutions for accurate reaction setup |
| KR102295290B1 (ko) | 2014-07-10 | 2021-08-30 | 플루어레센트릭 인코포레이티드 | Dna 증폭 기술 |
| EP3218515B1 (de) | 2014-11-10 | 2023-04-26 | F. Hoffmann-La Roche AG | Therapeutische und diagnostische verfahren für il-33-vermittelte erkrankungen |
| US9708647B2 (en) | 2015-03-23 | 2017-07-18 | Insilixa, Inc. | Multiplexed analysis of nucleic acid hybridization thermodynamics using integrated arrays |
| ES2787073T3 (es) | 2015-08-17 | 2020-10-14 | Kura Oncology Inc | Métodos para tratar pacientes con cáncer con inhibidores de la farnesiltransferasa |
| US9499861B1 (en) | 2015-09-10 | 2016-11-22 | Insilixa, Inc. | Methods and systems for multiplex quantitative nucleic acid amplification |
| WO2017155858A1 (en) | 2016-03-07 | 2017-09-14 | Insilixa, Inc. | Nucleic acid sequence identification using solid-phase cyclic single base extension |
| WO2017184968A1 (en) | 2016-04-22 | 2017-10-26 | Kura Oncology, Inc. | Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors |
| WO2017201315A1 (en) | 2016-05-18 | 2017-11-23 | Roche Sequencing Solutions, Inc. | Quantitative real time pcr amplification using an electrowetting-based device |
| WO2018050824A1 (en) | 2016-09-15 | 2018-03-22 | Roche Diagnostics Gmbh | Methods for performing multiplexed pcr |
| HUE053927T2 (hu) | 2016-11-03 | 2021-07-28 | Kura Oncology Inc | Farneziltranszferáz inhibitorok rák kezelésében történõ alkalmazásra |
| US11031099B2 (en) | 2016-11-09 | 2021-06-08 | Roche Molecular Systems, Inc. | Detection of sequence variants |
| ES2892157T3 (es) | 2017-02-21 | 2022-02-02 | Kura Oncology Inc | Métodos de tratamiento del cáncer con inhibidores de farnesil transferasa |
| US9956215B1 (en) | 2017-02-21 | 2018-05-01 | Kura Oncology, Inc. | Methods of treating cancer with farnesyltransferase inhibitors |
| US10806730B2 (en) | 2017-08-07 | 2020-10-20 | Kura Oncology, Inc. | Methods of treating cancer with farnesyltransferase inhibitors |
| CA3071854A1 (en) | 2017-08-07 | 2019-02-14 | Kura Oncology, Inc. | Methods of treating cancer with farnesyltransferase inhibitors |
| AU2019218128A1 (en) | 2018-02-09 | 2020-09-17 | Genentech, Inc. | Therapeutic and diagnostic methods for mast cell-mediated inflammatory diseases |
| EP3873469A2 (de) | 2018-11-01 | 2021-09-08 | Kura Oncology, Inc. | Verfahren zur behandlung von krebs mit farnesyltransferase-inhibitoren |
| WO2020180663A1 (en) | 2019-03-01 | 2020-09-10 | Kura Oncology, Inc. | Methods of treating cancer with farnesyltransferase inhibitors |
| CN113924041A (zh) | 2019-03-14 | 2022-01-11 | 因斯利克萨公司 | 基于时间门控的荧光检测的方法和系统 |
| SG11202110472WA (en) | 2019-03-29 | 2021-10-28 | Kura Oncology Inc | Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors |
| US20220168296A1 (en) | 2019-04-01 | 2022-06-02 | Kura Oncology, Inc. | Methods of treating cancer with farnesyltransferase inhibitors |
| WO2020223583A1 (en) | 2019-05-02 | 2020-11-05 | Kura Oncology, Inc. | Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors |
| WO2021180858A1 (en) | 2020-03-13 | 2021-09-16 | Medimmune Limited | Therapeutic methods for the treatment of subjects with risk alelles in il33 |
| JP2024500169A (ja) | 2020-12-22 | 2024-01-04 | エフ． ホフマン－ラ ロシュ アーゲー | 大ストークスシフト蛍光色素を使用して多重化リアルタイムｐｃｒを行うための方法 |
| WO2023104812A1 (en) | 2021-12-09 | 2023-06-15 | F. Hoffmann-La Roche Ag | Mass based detection of pcr amplicons |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1307480C (en) * | 1985-07-10 | 1992-09-15 | Nanibhushan Dattagupta | Prolonged chemiluminescence |
| FR2627590A1 (fr) * | 1988-02-24 | 1989-08-25 | Ire Celltarg Sa | Sonde d'acides nucleiques comportant un nucleotide terminal modifie chimiquement en 5(prime) (oh) en vue de son marquage non radioactif et procedes de preparation |
| JPH05505526A (ja) * | 1990-03-14 | 1993-08-19 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 多発光団蛍光プローブ |
| US5210015A (en) * | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| US5994056A (en) * | 1991-05-02 | 1999-11-30 | Roche Molecular Systems, Inc. | Homogeneous methods for nucleic acid amplification and detection |
| KR950701979A (ko) * | 1992-06-08 | 1995-05-17 | 다니엘 엘. 캐시앙 | 단핵 세포로부터 핵산의 조제 방법(Preparation of Nucleic Acid from Mononuclear Cells) |
| US5491063A (en) * | 1994-09-01 | 1996-02-13 | Hoffmann-La Roche Inc. | Methods for in-solution quenching of fluorescently labeled oligonucleotide probes |
-
1994
- 1994-11-23 US US08/347,657 patent/US5571673A/en not_active Expired - Lifetime
-
1995
- 1995-11-15 DE DE69522176T patent/DE69522176T2/de not_active Expired - Lifetime
- 1995-11-15 PT PT95117981T patent/PT713921E/pt unknown
- 1995-11-15 DK DK95117981T patent/DK0713921T3/da active
- 1995-11-15 ES ES95117981T patent/ES2162630T3/es not_active Expired - Lifetime
- 1995-11-15 EP EP95117981A patent/EP0713921B1/de not_active Expired - Lifetime
- 1995-11-15 AT AT95117981T patent/ATE204333T1/de active
- 1995-11-21 CA CA002163388A patent/CA2163388C/en not_active Expired - Lifetime
- 1995-11-21 NZ NZ280506A patent/NZ280506A/en not_active IP Right Cessation
- 1995-11-22 AU AU39010/95A patent/AU700885B2/en not_active Expired
- 1995-11-22 JP JP30430795A patent/JP3600333B2/ja not_active Expired - Lifetime
- 1995-11-23 KR KR1019950043097A patent/KR100431421B1/ko not_active IP Right Cessation
- 1995-11-23 CN CN95121850A patent/CN1131320C/zh not_active Expired - Lifetime
- 1995-11-23 RU RU95120014A patent/RU2149186C1/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| EP0713921A2 (de) | 1996-05-29 |
| CN1131320C (zh) | 2003-12-17 |
| ES2162630T3 (es) | 2002-01-01 |
| US5571673A (en) | 1996-11-05 |
| ATE204333T1 (de) | 2001-09-15 |
| NZ280506A (en) | 1997-07-27 |
| CA2163388A1 (en) | 1996-05-24 |
| CN1133888A (zh) | 1996-10-23 |
| RU2149186C1 (ru) | 2000-05-20 |
| EP0713921A3 (de) | 1996-09-11 |
| KR960017858A (ko) | 1996-06-17 |
| CA2163388C (en) | 2008-01-15 |
| EP0713921B1 (de) | 2001-08-16 |
| AU700885B2 (en) | 1999-01-14 |
| JPH08220092A (ja) | 1996-08-30 |
| DE69522176T2 (de) | 2002-05-29 |
| DK0713921T3 (da) | 2001-11-12 |
| AU3901095A (en) | 1996-05-30 |
| JP3600333B2 (ja) | 2004-12-15 |
| PT713921E (pt) | 2002-02-28 |
| KR100431421B1 (ko) | 2004-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69522176D1 (de) | Verfahren zur Dämpfung der Fluoreszenz von Fluoreszenzmarkierten Oligonukleotiden in Lösung | |
| DE69531133D1 (de) | Verfahren zur Dämpfung der Fluoreszene in Lösung von Fluoreszenzmarkierten Oligonucleotidsonden | |
| US6716394B2 (en) | DNA sequencing using multiple fluorescent labels being distinguishable by their decay times | |
| US6447724B1 (en) | DNA sequencing using multiple fluorescent labels being distinguishable by their decay times | |
| ATE364718T1 (de) | Verfahren zur vervielfältigung von nukleinsäure | |
| ATE414096T1 (de) | Verfahren zum nachweis und zur quantifizierung von analyten in komplexen mischungen | |
| DE69937447D1 (de) | Verfahren zur erkennung von nukleinsäuren | |
| RU95120014A (ru) | Способы гашения в растворе флуорисцентномеченых олигонуклеотидных зондов | |
| ATE206764T1 (de) | Verfahren zum sensitiven nachweis von nukleinsäuren | |
| DE69333242D1 (de) | Verfahren, reagenz und salz zum nachweis und amplifikation von nukleinsäuresequenzen | |
| ATE305476T1 (de) | Met/fret markierte amplifikationsoligonukleotide und ihre vewendung in verfahren | |
| ES2173670T3 (es) | Procedimiento de identificacion de acidos nucleicos mediante espectrometria de masas laser de desorcion/ionizacion asistidas por matriz. | |
| DE60133111D1 (de) | Verfahren zur erkennung und zum assay von nukleinsäuresequenzen | |
| ATE220726T1 (de) | Oligonukleotid-primer für amplifizierung von hcv- nukleinsäure | |
| ATE298804T1 (de) | Verfahren zur nachweis von nukleinsäuren | |
| ATE325893T1 (de) | Fluorometrisches verfahren zur überwachung und zum nachweis von nucleinsäure-amplifizierung | |
| DE502005010036D1 (de) | Verfahren zur geno- und pathotypisierung von pseudomonas aeruginosa | |
| ATE455864T1 (de) | Verfahren zum nachweis von in einer polymerase- kettenreaktion amplifizierten nukleinsäuremolekülen | |
| JP2003506068A5 (de) | ||
| ATE287969T1 (de) | Amplifizierungsverfahen zum nachweis von zielnukleinsäuren unter verwendung von fluoreszenzenergieübertragung | |
| EP1619258A4 (de) | Verfahren zum nachweis oder zur quantitativen bestimmung der mitochondrialen dna-variation 3243 und kit dafür | |
| JP2019154396A (ja) | 核酸検出方法、並びに、それに用いる標的核酸検出用プローブ、及び標的核酸検出用デバイス | |
| JP2007215496A (ja) | 核酸解析法におけるプローブ核酸の蛍光標識方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |